Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer And PBMs Delay Sale Of Generic Lipitor
Pharmalot
Monday, November 14, 2011 - 11:06am
tags:
Pfizer, PBMs, generics, Lipitor, Ranbaxy, Watson
Study Finds Co-Payments Discourage Drug Treatments
NY Times, NY
Monday, November 14, 2011 - 11:04am
tags:
co-pays, insurance, patients
Ziopharm Oncology presents preclinical data for darinaparsin
Yahoo/Fly on the Wall
Monday, November 14, 2011 - 10:54am
tags:
Ziopharm, darinaparsin, prostate cancer
Earnings Update: Titan Pharmaceuticals
Seeking Alpha
Monday, November 14, 2011 - 10:50am
tags:
earnings, Titan
Endo stops development of implant to treat abnormal growth
Reuters
Monday, November 14, 2011 - 10:49am
tags:
Endo, Octreotide
India's Cipla Q2 net up 17.5 pct, beats f'cast
Reuters
Monday, November 14, 2011 - 10:48am
tags:
earnings, India, Cipla
Ampio Is A Potential Major Player In The Anti-Inflammatory Market
Seeking Alpha
Monday, November 14, 2011 - 10:47am
tags:
Ampio, anti-inflammatory, Ampion
J&J-Bayer Blood Thinner May Enter $1B Market
Bloomberg
Monday, November 14, 2011 - 10:46am
tags:
bloodthinners, JNJ, Bayer, Xarelto
Sun Pharma Q2 net profit up 19% at Rs 598 crore
Economic Times, India
Sunday, November 13, 2011 - 12:33pm
tags:
Sun Pharma, earnings
Teva loses birth-control pill appeal in US
Globes, Israel
Sunday, November 13, 2011 - 12:32pm
tags:
Teva Pharmaceuticals, birth control, Seasonique, Watson Pharmaceuticals, generics, lawsuits
Targacept still in game, CEO says
Winston-Salem Journal, NC
Sunday, November 13, 2011 - 12:31pm
tags:
Targacept
Teva’s Slide Widens Discount as Ceragon Sinks: Israel Overnight
Bloomberg
Sunday, November 13, 2011 - 12:29pm
tags:
Teva Pharmaceuticals
Eli Lilly faces tough times with patent losses
Yahoo/Reuters
Sunday, November 13, 2011 - 12:16pm
tags:
Eli Lilly
ATLAS ACS 2-TIMI 51: Rivaroxaban Beneficial in Low-Risk ACS Population
Forbes
Sunday, November 13, 2011 - 12:15pm
tags:
rivaroxaban, Xarelto, acute coronary syndrome, anticoagulants, anti-platelets
Bristol, Pfizer clot drug fails to help ill patients
Reuters
Sunday, November 13, 2011 - 12:12pm
tags:
Bristol-Myers Squibb, Pfizer, Eliquis, Apixaban, anticoagulants
TRACER: Novel Antiplatelet Vorapaxar Runs Into Trouble in ACS
Forbes
Sunday, November 13, 2011 - 12:11pm
tags:
Vorapaxar, TRACER, acute coronary syndrome, anti-platelet, Merck
Let's Check Amgen's Growth
Motley Fool
Sunday, November 13, 2011 - 12:07pm
tags:
Amgen
Preliminary Data Demonstrate that 40 mg Daily Dose of Cabozantinib Yields a High Rate of Bone Scan Response in mCRPC
Yahoo/BusinessWire
Sunday, November 13, 2011 - 12:06pm
tags:
prostate cancer, cabozantinib, bone cancer, Exelixis
Enzon Presents Clinical and Preclinical Data on mRNA Antagonists at 2011 AACR-NCI-EORTC Meeting
Yahoo/MarketWire
Sunday, November 13, 2011 - 12:04pm
tags:
Enzon, EZN-3042, EZN-3920
AstraZeneca says new antidepressant not ready for pharmaceutical sales in U.S.
medreps
Saturday, November 12, 2011 - 12:57pm
tags:
TC-5214, AstraZeneca, antidepressants

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.